Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma

PURPOSE: Activation of the mitogen-activated protein kinase (MAPK) pathway and the phosphatidylinositol 3-kinase/AKT pathway seems to be critical for melanoma proliferation. Components of these pathways are client proteins of heat-shock protein 90 (hsp90), suggesting that inhibition of hsp90 could h...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Solit, David B., Osman, Iman, Polsky, David, Panageas, Katherine S., Daud, Adil, Goydos, James S., Teitcher, Jerrold, Wolchok, Jedd D., Germino, F. Joseph, Krown, Susan E., Coit, Daniel, Rosen, Neal, Chapman, Paul B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2629404/
https://ncbi.nlm.nih.gov/pubmed/19088048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-1002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados